Dendritic cell-derived exosomes (DEX) have shown great potential in priming the immune system by presenting tumor antigens, which active both cytotoxic CD8+ and helper CD4+ T cells, driving a strong anti-tumor immune response. The gene discussed is CD4; the disease is neoplasm.